Taiki Uemoto
R&D Center, Biofermin Pharmaceutical Co., Ltd., Kobe, Japan
- Papers in database
- 2
- Years active
- 2021 – 2022
Papers (2)
- 2022Correction: Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis.10.1371/journal.pone.0267927
- 2021Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis10.1371/journal.pone.0248584